NEW YORK ( TheStreet) -- Gen-Probe (Nasdaq: GPRO) hit a new 52-week high Tuesday as it is currently trading at $82.06, above its previous 52-week high of $82 with 1.1 million shares traded as of 10:05 a.m. ET. Average volume has been 1.1 million shares over the past 30 days. Gen-Probe has a market cap of $3.71 billion and is part of the services sector and diversified services industry. Shares are up 37.5% year to date as of the close of trading on Monday. Gen-Probe Incorporated engages in the development, manufacture, and marketing of molecular diagnostic products and services that are used primarily to diagnose human diseases and screen donated human blood. The company has a P/E ratio of 77.4, below the average diversified services industry P/E ratio of 78.9 and above the S&P 500 P/E ratio of 17.7.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!